|
Back to:
Cyheptamide
(Last updated February 2023)
Figure 1. The molecular diagram of Cyheptamide.
CSP studies
| REFCODE | |
| Formula | C16 H15 N1 O1 |
| Common Name | Cyheptamide |
| IUPAC Systematic Name | 10,11-dihydro-5H-dibenzocycloheptene-5-carboxamide |
| Other Names | |
| CSD Refcodes | TEVSOD, TEVSOD01, TEVSOD02 |
| |
| Search Identifier | |
| Scientist | Rui Guo |
| Date | 2013 |
| Publication | Srirambhatla, V. K.; Guo, R.; Price, S. L.; Florence, A. J., Chemical Communications 2016, 52, 7384-7386. |
| Energy model | |
| Study_ID | 10 |
| Programs | Flexible CrystalPredictor (1.6), CrystalOptimizer (2.3), DMACRYS (2.0.8RC1) |
| Location on S Drive | /CHEMISTRY_CPOSS\CarbamazepineSeries\Cyheptamide_CO |
| Potential Description | CrystalOptimizer with PBE0/6-31G(d,p) Intra and GDMA2.2(PBE0/6-31G(d,p)) + FIT |
| Intramolecular Description | PBE0/6-31G(d,p) |
| pDFT structures | |
| Energy model | |
| Study_ID | 30 |
| Programs | Study_ID=10, DMACRYS (2.0.8RC1) |
| Location on S Drive | /CHEMISTRY_CPOSS\CarbamazepineSeries\Cyheptamide_PCM |
| Potential Description | GDMA2.2(PCMdielectric3(PBE0/6-31G(d,p)) + FIT |
| Intramolecular Description | PCMdielectric=3(PBE0/6-31G(d,p)) |
| |
| Search Identifier | |
| Scientist | Louise Price |
| Date | 2010 |
| Publication | No publication planned. |
| Energy model | |
| Study_ID | 0 |
| Programs | MOLPAK, DMAREL (4.1.1) |
| Location on S Drive | \CHEMISTRY_CPOSS\0-EarlySearches\home\louise_price.eminerals\cyheptamide |
| Potential Description | DMA + FIT |
| Intramolecular Description | MP2/6-31G(d,p) |
Figure 2. Lattice Energy Landscapes of Cyheptamide. Energy models A1 and B1. Line chart comparing DFT+D energy models.
CSD structures (CSD version 6.01)
Table 1. Crystallographic information and experimental information of CSD entries for Cyheptamide. Different polymorphs, as ascertained by structure matching of 20 molecule coordination sphere in Mercury, are coloured differently. Reference polymorphs are outlined in bold.
| REFCODE | Spacegroup | Z' | a / Å | b / Å | c / Å | α / ° | β / ° | γ / ° | density / g cm-3 | Form | R factor | T / K | Year | Comment / reference | REFCODE |
| TEVSOD | P21/c | 1.0 | 5.6035 | 9.1716 | 23.579 | 90.0 | 96.752 | 90.0 | 1.3097 | polymorph I | 3.5 | at 150 K | 2007 | 10.1107/S160053680604983X | TEVSOD |
| TEVSOD01 | P-1 | 4.0 | 5.64910 | 19.5639 | 22.0741 | 84.217800 | 88.4073 | 83.6001 | 1.3070 | polymorph II | 4.2 | at 100 K | 2008 | 10.1039/b712547j | TEVSOD01 |
| TEVSOD02 | Pbca | 1.0 | 9.01710 | 11.0071 | 23.9483 | 90.0 | 90.0 | 90.0 | 1.3262 | polymorph III | 4.41 | 123 K | 2016 | 10.1039/C6CC01710J | TEVSOD02 |
Other Notes
Form I (TEVSOD) is isostructural with dihydrocarbamazepine monoclinic form.
Form II (TEVSOD01) is isostructural with carbamazepine form I and cytenamide form II.
Form III (TEVSOD02) is isostructural with carbamazepine form V and dihydrocarbamazepine form II.
|